Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?

被引:23
作者
Askling, J
Sorensen, P
Ekbom, A
Frisch, M
Melbye, M
Glimelius, B
Hjalgrim, H
机构
[1] Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden
[2] State Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark
[3] Harvard Sch Publ Hlth, Boston, MA USA
[4] NCI, Viral Epidemiol Branch, Rockville, MD 20852 USA
[5] Univ Uppsala Hosp, Uppsala, Sweden
关键词
carcinoma; squamous cell; lymphoma; non-Hodgkin; colonic neoplasms; prostatic neoplasms; lung neoplasms; breast neoplasms;
D O I
10.7326/0003-4819-131-9-199911020-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Nonmelanoma skin cancer is associated with increased occurrence of subsequent cancer and death from cancer, but it is not known whether a history of skin cancer is associated with poor prognosis after a second diagnosis of cancer. Objective: To determine whether history of squamous-cell skin cancer is a marker of poor prognosis in patients with cancer. Design: Population-based cohort study. Setting: Sweden, 1958 to 1996. Patients: All patients in the Swedish Cancer Registry with or without a first diagnosis of squamous-cell skin cancer and a subsequent or first diagnosis of non-Hodgkin lymphoma (including chronic lymphocytic leukemia) or cancer of the colon, breast, prostate, or lung. Measurements: Relative risk (RR) for death determined by using Cox proportional hazards regression analysis. Results: Patients with a history of squamous-cell skin cancer had a significantly greater risk for death than those with no such history after receiving a diagnosis of non-Hodgkin lymphoma (RR, 1.33). colon cancer (RR, 1.24), breast cancer (RR, 1.19), or prostate cancer (RR, 1.17). Patients with lung cancer and a history of squamous-cell skin cancer who survived for 1 year after diagnosis of lung cancer also had an increased risk for death (RR, 1.29). Conclusion: Patients with a registered history of squamous-cell skin cancer have a poor prognosis after diagnosis of subsequent cancer and warrant careful medical attention.
引用
收藏
页码:655 / +
页数:6
相关论文
共 28 条
[1]  
Adami HO, 1996, INT J CANCER, V67, P764, DOI 10.1002/(SICI)1097-0215(19960917)67:6<764::AID-IJC3>3.0.CO
[2]  
2-P
[3]   EVIDENCE OF AN ASSOCIATION BETWEEN NON-HODGKINS-LYMPHOMA AND SKIN-CANCER [J].
ADAMI, J ;
FRISCH, M ;
YUEN, J ;
GLIMELIUS, B ;
MELBYE, M .
BRITISH MEDICAL JOURNAL, 1995, 310 (6993) :1491-1495
[4]  
[Anonymous], 1996, ACTA ONCOL, V35, P47
[5]   Monitoring populations for DNA repair deficiency and for cancer susceptibility [J].
Au, WW ;
Wilkinson, GS ;
Tyring, SK ;
Legator, MS ;
ElZein, R ;
Hallberg, L ;
Heo, MY .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 :579-584
[6]   CANCER RISK AFTER RENAL-TRANSPLANTATION IN THE NORDIC COUNTRIES, 1964-1986 [J].
BIRKELAND, SA ;
STORM, HH ;
LAMM, LU ;
BARLOW, L ;
BLOHME, I ;
FORSBERG, B ;
EKLUND, B ;
FJELDBORG, O ;
FRIEDBERG, M ;
FRODIN, L ;
GLATTRE, E ;
HALVORSEN, S ;
HOLM, NV ;
JAKOBSEN, A ;
JORGENSEN, HE ;
LADEFOGED, J ;
LINDHOLM, T ;
LUNDGREN, G ;
PUKKALA, E .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (02) :183-189
[7]   A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA [J].
BRASH, DE ;
RUDOLPH, JA ;
SIMON, JA ;
LIN, A ;
MCKENNA, GJ ;
BADEN, HP ;
HALPERIN, AJ ;
PONTEN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10124-10128
[8]  
CLAYTON D, 1993, STAT METHODS EPIDEMI
[9]   Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: Time to consider the TH1/TH2 paradigm [J].
Clerici, M ;
Shearer, GM ;
Clerici, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (04) :261-263
[10]  
Dreyer L, 1997, APMIS, V105, P9